Your search for prostate cancer returned 377 results

Your search for prostate cancer returned 377 results

Sort Results:

Relevant Recent
Evidence-Based Medicine

Prostate cancer screening may not reduce mortality

Level 2: Mid-level evidenceIn two recent randomized trials, prostate cancer screening did not appear to show clinically significant benefits. The large European Randomized Study of Screening for Prostate Cancer (ERSPC) evaluated prostate-specific antigen (PSA) testing in 182,000 men with median follow-up of nine years (N Engl J Med. 2009;360:1320-1328; available at content.nejm.org/cgi/content/full/360/13/1320, accessed May 12,…
News

More accurate test may replace PSA

An experimental blood test detects prostate cancer so accurately that it may supplant prostate-specific antigen (PSA) levels as a screening tool. Researchers at Johns Hopkins University in Baltimore discovered an early prostate cancer antigen (EPCA-2) that functions as a biomarker. In a sample of 330 men, EPCA-2 levels were positive in 94% of those who…
News

Prevention of prostate cancer

Men with no signs of prostate cancer should talk to their provider about taking a 5a-reductase inhibitor (5-ARI) for seven years to ward off the disease.
Next post in Web Exclusives